Literature DB >> 30341509

Updated Genetic Testing of Primary Hyperoxaluria Type 1 in a Chinese Population: Results from a Single Center Study and a Systematic Review.

Dun-Feng Du1,2, Qian-Qian Li3, Chen Chen4, Shu-Mei Shi3, Yuan-Yuan Zhao1,2, Ji-Pin Jiang1,2, Dao-Wen Wang4, Hui Guo1,2, Wei-Jie Zhang5,6, Zhi-Shui Chen7,8.   

Abstract

Primary hyperoxaluria type 1 (PH1) is a rare but devastating autosomal recessive inherited disease caused by mutations in gene AGXT. Pathogenic mutations of AGXT were mostly reported in Caucasian but infrequently in Asian, especially in Chinese. To update the genotypes of PH1 in the Chinese population, we collected and identified 7 Chinese probands with PH1 from 2013 to 2017 in our center, five of whom had delayed diagnosis and failed in kidney transplantation. Samples of peripheral blood DNA from the 7 patients and their family members were collected and sequencing analysis was performed to test the mutations of gene AGXT. Western blotting and enzyme activity analysis were conducted to evaluate the function of the mutations. Furthermore, a systematic review from 1998 to 2017 was performed to observe the genetic characteristics between Chinese and Caucasian. The results showed that a total of 12 mutations were identified in the 7 pedigrees. To the best of our knowledge, 2 novel variants of AGXT, p.Gly41Trp and p.Leu33Met, were first reported. Bioinformatics and functional analysis showed that only 7 mutations led to a reduced expression of alanine-glyoxylate amino transferase (AGT) at a protein level. The systematic review revealed significant population heterogeneity in PH1. In conclusion, new genetic subtypes and genetic characteristics of PH1 are updated in the Chinese population. Furthermore, a genotype-phenotype correlation is found in PH1.

Entities:  

Keywords:  AGXT; Chinese population; gene sequencing; primary hyperoxaluria type 1

Mesh:

Substances:

Year:  2018        PMID: 30341509     DOI: 10.1007/s11596-018-1941-y

Source DB:  PubMed          Journal:  Curr Med Sci        ISSN: 2523-899X


  21 in total

1.  Primary hyperoxaluria Type 1: indications for screening and guidance for diagnosis and treatment.

Authors:  Pierre Cochat; Sally-Anne Hulton; Cécile Acquaviva; Christopher J Danpure; Michel Daudon; Mario De Marchi; Sonia Fargue; Jaap Groothoff; Jérôme Harambat; Bernd Hoppe; Neville V Jamieson; Markus J Kemper; Giorgia Mandrile; Martino Marangella; Stefano Picca; Gill Rumsby; Eduardo Salido; Michael Straub; Christiaan S van Woerden
Journal:  Nephrol Dial Transplant       Date:  2012-05       Impact factor: 5.992

Review 2.  Primary hyperoxaluria.

Authors:  Pierre Cochat; Gill Rumsby
Journal:  N Engl J Med       Date:  2013-08-15       Impact factor: 91.245

3.  M-CAP eliminates a majority of variants of uncertain significance in clinical exomes at high sensitivity.

Authors:  Karthik A Jagadeesh; Aaron M Wenger; Mark J Berger; Harendra Guturu; Peter D Stenson; David N Cooper; Jonathan A Bernstein; Gill Bejerano
Journal:  Nat Genet       Date:  2016-10-24       Impact factor: 38.330

Review 4.  Hyperoxaluria and systemic oxalosis: an update on current therapy and future directions.

Authors:  Bodo B Beck; Heike Hoyer-Kuhn; Heike Göbel; Sandra Habbig; Bernd Hoppe
Journal:  Expert Opin Investig Drugs       Date:  2012-11-21       Impact factor: 6.206

5.  Genome-wide association identifies a susceptibility locus for coronary artery disease in the Chinese Han population.

Authors:  Fan Wang; Cheng-Qi Xu; Qing He; Jian-Ping Cai; Xiu-Chun Li; Dan Wang; Xin Xiong; Yu-Hua Liao; Qiu-Tang Zeng; Yan-Zong Yang; Xiang Cheng; Cong Li; Rong Yang; Chu-Chu Wang; Gang Wu; Qiu-Lun Lu; Ying Bai; Yu-Feng Huang; Dan Yin; Qing Yang; Xiao-Jing Wang; Da-Peng Dai; Rong-Feng Zhang; Jing Wan; Jiang-Hua Ren; Si-Si Li; Yuan-Yuan Zhao; Fen-Fen Fu; Yuan Huang; Qing-Xian Li; Sheng-Wei Shi; Nan Lin; Zhen-Wei Pan; Yue Li; Bo Yu; Yan-Xia Wu; Yu-He Ke; Jian Lei; Nan Wang; Chun-Yan Luo; Li-Ying Ji; Lian-Jun Gao; Lei Li; Hui Liu; Er-Wen Huang; Jin Cui; Na Jia; Xiang Ren; Hui Li; Tie Ke; Xian-Qin Zhang; Jing-Yu Liu; Mu-Gen Liu; Hao Xia; Bo Yang; Li-Song Shi; Yun-Long Xia; Xin Tu; Qing K Wang
Journal:  Nat Genet       Date:  2011-03-06       Impact factor: 38.330

6.  Characterization and chromosomal mapping of a genomic clone encoding human alanine:glyoxylate aminotransferase.

Authors:  P E Purdue; M J Lumb; M Fox; G Griffo; C Hamon-Benais; S Povey; C J Danpure
Journal:  Genomics       Date:  1991-05       Impact factor: 5.736

7.  Clinical implications of mutation analysis in primary hyperoxaluria type 1.

Authors:  Christiaan S van Woerden; Jaap W Groothoff; Frits A Wijburg; Carla Annink; Ronald J A Wanders; Hans R Waterham
Journal:  Kidney Int       Date:  2004-08       Impact factor: 10.612

8.  Human peroxisomal L-alanine: glyoxylate aminotransferase. Evolutionary loss of a mitochondrial targeting signal by point mutation of the initiation codon.

Authors:  Y Takada; N Kaneko; H Esumi; P E Purdue; C J Danpure
Journal:  Biochem J       Date:  1990-06-01       Impact factor: 3.857

9.  Multiple mechanisms of action of pyridoxine in primary hyperoxaluria type 1.

Authors:  Sonia Fargue; Gill Rumsby; Christopher J Danpure
Journal:  Biochim Biophys Acta       Date:  2013-04-15

10.  High-performance liquid chromatographic microassay for L-alanine:glyoxylate aminotransferase activity in human liver.

Authors:  M Petrarulo; S Pellegrino; M Marangella; D Cosseddu; F Linari
Journal:  Clin Chim Acta       Date:  1992-06-30       Impact factor: 3.786

View more
  7 in total

1.  Characteristics of the genotype and phenotype in Chinese primary hyperoxaluria type 1 populations.

Authors:  Fangzhou Zhao; Jun Li; Lei Tang; Chunming Li; Wenying Wang; Chen Ning
Journal:  Urolithiasis       Date:  2020-06-18       Impact factor: 3.436

2.  Human MiR-4660 regulates the expression of alanine-glyoxylate aminotransferase and may be a biomarker for idiopathic oxalosis.

Authors:  Xin Tu; Yuanyuan Zhao; Qianqian Li; Xiao Yu; Yang Yang; Shumei Shi; Zuochuan Ding; Yan Miao; Zhimiao Zou; Xinqiang Wang; Jipin Jiang; Dunfeng Du
Journal:  Clin Exp Nephrol       Date:  2019-03-09       Impact factor: 2.801

Review 3.  Genetic assessment in primary hyperoxaluria: why it matters.

Authors:  Giorgia Mandrile; Bodo Beck; Cecile Acquaviva; Gill Rumsby; Lisa Deesker; Sander Garrelfs; Asheeta Gupta; Justine Bacchetta; Jaap Groothoff
Journal:  Pediatr Nephrol       Date:  2022-06-13       Impact factor: 3.714

4.  Novel mutations in response to vitamin B6 in primary hyperoxaluria type 1 after only kidney transplantation: a case report.

Authors:  Yuanyuan Zhao; Yang Yang; Ping Zhou; Jipin Jiang; Zhishui Chen; Dunfeng Du
Journal:  Transl Androl Urol       Date:  2020-12

5.  Next-generation sequencing in identification of pathogenic variants in primary hyperoxaluria among 21 Egyptian families: Identification of two novel AGXT gene mutations.

Authors:  Hoda A Ahmed; Fatina I Fadel; Mohamed A Abdel Mawla; Doaa M Salah; Mohamed Gamal Fathallah; Khalda Amr
Journal:  Mol Genet Genomic Med       Date:  2022-06-03       Impact factor: 2.473

6.  A novel nonsense variant of the AGXT identified in a Chinese family: special variant research in the Chinese reference genome.

Authors:  Chang Bao Xu; Xu Dong Zhou; Hong En Xu; Yong Li Zhao; Xing Hua Zhao; Dan Hua Liu; Yong An Tian; Xin Xin Hu; Jing Yuan Guan; Jian Cheng Guo; Wen Xue Tang; Xia Xue
Journal:  BMC Nephrol       Date:  2021-03-10       Impact factor: 2.388

7.  Clinical analysis of 13 children with primary hyperoxaluria type 1.

Authors:  Jin-Ai Lin; Xin Liao; Wenlin Wu; Lixia Xiao; Longshan Liu; Jiang Qiu
Journal:  Urolithiasis       Date:  2021-03-15       Impact factor: 3.436

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.